EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    3.1.1.23 | Fatty Liver |
33672787 |
Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice. |
ongoing research
unassigned |
2
0 |
| 3.1.1.23 | Nervous System Diseases |
30354159 |
Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 3.1.1.23 | Neurodegenerative Diseases |
30354159 |
Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 3.1.1.23 | Alzheimer Disease |
28733897 |
Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.1.1.23 | Peripheral Nervous System Diseases |
23127915 |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
ongoing research
therapeutic application
unassigned |
2
4
0 |
| 3.1.1.23 | Congenital Abnormalities |
23953192 |
Anticholinesterase insecticide action at the murine male reproductive system. |
causal interaction
therapeutic application
unassigned |
2
2
0 |
| 3.1.1.23 | Neoplasms |
30914306 |
Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons. |
ongoing research
therapeutic application
unassigned |
2
2
0 |
| 3.1.1.23 | Demyelinating Diseases |
25130621 |
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. |
therapeutic application
unassigned |
1
0 |
| 3.1.1.23 | Cerebral Cortical Thinning |
31695165 |
Brain structural changes in cannabis dependence: association with MAGL. |
unassigned |
0 |
| 3.1.1.23 | Parkinson Disease |
29352424 |
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease. |
unassigned |
0 |
